We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pain Killing Protein Is Eight Times More Powerful than Morphine

By LabMedica International staff writers
Posted on 20 Oct 2008
Pain researchers have identified a protein produced by neurons that when injected into the spinal columns of experimental mice suppressed pain eight times more effectively than morphine did.

The protein under investigation, prostatic acid phosphatase (PAP) was shown by investigators at the University of North Carolina (Chapel Hill, USA) to be the same as a well-known neuron biomarker, fluoride-resistant acid phosphatase (FRAP). More...
This became apparent when mice genetically engineered to lack PAP activity were found to also lack FRAP.

The genetically engineered mice were more sensitive than normal mice to inflammatory pain and neuropathic pain, two common forms of chronic pain in humans. Furthermore, data published in the October 9, 2008, issue of the journal Neuron revealed that the increased pain sensitivities of the engineered mice diminished when they received injections of excess amounts of PAP into their spinal cords. The effectiveness of PAP injections was estimated to be about eight times that of morphine. Additionally, a single dose of PAP provided pain relief for up to three days, considerably longer than the five hours obtained from a dose of morphine.

"We were really blown away that a simple injection could have such a potent effect on pain,” said first author Dr. Mark J. Zylka, assistant professor of cell and molecular physiology at the University of North Carolina. "Not only that, but it appeared to work much better than the commonly used drug morphine. This protein has the potential to be a groundbreaking treatment for pain and has previously not been studied in pain-sensing neurons. It is entirely possible that PAP itself could be used as a treatment for pain, through an injection just like morphine, but we would like to modify it to be taken in pill form. By taking this field in a new direction, we are encouraged and hopeful that we will be able to devise new treatments for pain.”

Related Links:

University of North Carolina


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image: The LymphoTrack Flex suite is an integrated next-generation sequencing solution for identifying and tracking immunoglobulin and T-cell receptor gene rearrangements (Photo courtesy of Invivoscribe)

New NGS Suite Expands Clonality and MRD Research in Lymphoid Malignancies

Lymphoid malignancies require molecular tools that can distinguish clonal immune receptor rearrangements and track disease-related sequences over time. As immune receptor measurable residual disease analysis... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.